Professional Documents
Culture Documents
From *The Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Oakland Kaiser Hospital,
Oakland, California; and the Denver VA Medical Center, Denver, Colorado. This analysis was funded by the National
Cardiovascular Data Registry.
Manuscript received February 1, 2008; revised manuscript received May 5, 2008, accepted May 18, 2008.
380
Rao et al.
Trends in Radial and Femoral Approaches to PCI
Methods
Study population. The NCDR, which is cosponsored by
Rao et al.
Trends in Radial and Femoral Approaches to PCI
381
heparin use, direct thrombin inhibitor use, history of congestive heart failure, and peripheral vascular disease. The
effects of patient age (75 vs. 75 years), patient gender,
and PCI indication on the relationship between r-PCI and
the outcomes were assessed by including interaction terms
between arterial entry location (radial or femoral) and the
groups of interest in the models adjusted for NCDR risk
score. We repeated the analysis after excluding centers that
did not perform any r-PCI procedures during the study
period. A p value 0.05 was considered significant for all
tests. All statistical analyses were performed by the Duke
Clinical Research Institute using SAS software (version 9.0,
SAS Institute, Cary, North Carolina).
Results
Study population. Of the 725,549 procedures entered into the
NCDR during the study period, 593,094 PCI procedures
remained after applying the exclusion criteria. Of these, 7,804
(1.32%) procedures were performed via the radial artery approach. Figure 1 displays the prevalence of r-PCI across
hospitals; the vast majority of centers performed 10% of PCI
procedures via the radial artery approach. However, there were
7 centers in the database that performed 40% of PCI
procedures via the radial approach.
Table 1 displays the baseline characteristics of r-PCI
versus f-PCI procedures. r-PCI procedures were performed
in slightly younger patients and in patients with significantly
higher body mass index, and with a higher prevalence of
peripheral vascular disease compared with f-PCI. There was
a significantly lower prevalence of prior coronary artery
bypass graft surgery, prior renal failure, and NSTE ACS or
STEMI among r-PCI patients. In terms of procedure
characteristics, r-PCI procedures had longer fluoroscopy
times, but there was no significant difference between r-PCI
and f-PCI in terms of total volume of contrast used (median
100
90
88.78
80
70
60
50
40
30
20
3.79
10
1.32
1.16
1.32
2.15
0.33
0.83
0.33
4-5.99%
6-7.99%
8-9.99%
1019.99%
2029.99%
3039.99%
40%
0
0-1.99%
2-3.99%
% use of r-PCI
Figure 1. Proportion of PCI Cases Performed Via the Radial Artery
Proportion of percutaneous coronary intervention (PCI) cases performed via
the radial artery approach (r-PCI) across sites.
382
Rao et al.
Trends in Radial and Femoral Approaches to PCI
r-PCI (n 7,804)
f-PCI (n 585,290)
p Value
65.00
(56.00, 74.00)
64.00
(56.00, 73.00)
65.00
(56.00, 74.00)
0.01
34.34
29.09
34.41
0.01
28.95
(25.66, 33.11)
29.71
(26.13, 34.88)
28.94
(25.64, 33.09)
0.01
Diabetes mellitus
33.99
33.21
34.00
Hypertension
78.58
79.48
78.57
0.05
12.63
15.76
12.59
0.01
0.01
Characteristic
Demographics
Median age, yrs
(25th, 75th percentiles)
Female gender
Median BMI, kg/m2
(25th, 75th percentiles)
Medical comorbidities
0.14
5.45
4.16
5.46
Prior PCI
38.55
37.70
38.56
0.12
Prior CABG
20.68
10.43
20.82
0.01
41.46
47.26
41.38
NSTE ACS
54.46
49.65
54.53
4.08
3.09
Procedural characteristics
0.01
Procedure indication
STEMI
4.09
11.40
(7.10, 18.50)
13.50
(8.70, 21.50)
11.30
(7.00, 18.50)
0.01
39.79
36.95
39.83
0.01
Unfractionated heparin
52.84
77.27
52.52
0.01
Low-molecular-weight heparin
16.40
15.70
16.41
0.09
Bivalirudin
39.27
13.76
39.62
0.01
431.00
(304.00, 585.00)
494.00
(291.50, 633.00)
431.00
(304.00, 585.00)
Hospital characteristics
Number of beds, median
(25th, 75th percentiles)
University hospital
Number of annual PCI cases, median
(25th, 75th percentiles)
8.62
955.54
(628.42, 1,645.00)
11.89
866.83
(472.21, 1,966.50)
8.58
955.54
(630.82, 1,645.00)
0.01
0.01
0.01
Rao et al.
Trends in Radial and Femoral Approaches to PCI
3.5
3
4
3.5
3
2.5
1.5
1
1.5
0.5
20
06
20
06
Q
tr
4
2
Q 006
tr
1
20
07
tr
2
tr
3
05
06
20
20
tr
1
05
05
20
tr
3
tr
4
tr
2
Q
05
20
20
04
20
tr
1
20
tr
4
tr
3
04
04
tr
2
20
20
tr
1
tr
3
20
04
tr
2
04
20
04
(N
=2
65
)
(N
=3
20
76
04
)
Q
(N
tr
4
=3
20
91
04
5)
(N
Q
tr
=6
1
58
20
9)
05
Q
(6
tr
34
2
20
61
05
)
Q
(6
tr
56
3
20
12
Q
05
)
tr
4
(6
20
55
05
88
Q
(N
)
tr
1
=6
20
58
06
14
Q
(N
)
tr
2
=7
20
95
06
22
Q
(N
)
tr
3
=8
20
23
06
65
Q
(N
)
tr
4
=7
20
93
06
71
(N
)
Q
tr
=7
1
76
20
13
07
)
(N
=2
60
3)
0.5
Q
tr
1
2.5
383
3.5
4
Males
Females
2.5
Stable angina
NSTE ACS
STEMI
1.5
0.5
0
20
05
2
Q 005
tr
4
2
Q 005
tr
1
2
Q 006
tr
2
2
Q 006
tr
3
2
Q 006
tr
4
2
Q 006
tr
1
20
07
tr
3
05
04
20
tr
2
tr
4
tr
1
Q
20
04
04
20
20
tr
3
Q
04
20
tr
2
tr
1
Q
05
04
20
05
tr
3
20
05
Q
tr
4
20
05
Q
tr
1
20
06
Q
tr
2
20
06
Q
tr
3
20
06
Q
tr
4
20
06
Q
tr
1
20
07
tr
2
tr
1
20
20
04
Q
tr
4
20
tr
3
04
20
tr
2
Q
tr
1
20
04
100
95.53
94.68
90
r-PCI
f-PCI
Incidence (%)
80
70
60
50
40
30
20
Outcome
10
0.19
0
Procedure
success
0.70
Vascular
complication
0.79
1.83
Bleeding
complication
Procedural success
1.09 (0.971.23)
1.02 (0.921.12)
0.38 (0.260.54)
0.42 (0.310.56)
risk, bifurcation disease, chronic total occlusion, and pre-procedure Thrombolysis In Myocardial
Infarction flow grade. Any bleeding complication model adjusted for American College of
Cardiology-National Cardiovascular Data Registry risk score (13), gender (female as reference),
body mass index, glycoprotein IIb/IIIa inhibitor use, unfractionated heparin use, direct thrombin
inhibitor use, congestive heart failure, and peripheral vascular disease.
CI confidence interval; other abbreviations as in Table 1.
384
Rao et al.
Trends in Radial and Femoral Approaches to PCI
A
3.5
Bleeding
Complications
2.99
Discussion
2.5
2.05
Vascular
Complications
1.42
1.5
r-PCI
f-PCI
1.00
1
0.62
0.5
0.47
0.44
0.13
0
< 75 yrs
3.5
75 yrs
< 75 yrs
75 yrs
Bleeding
Complications
2.86
2.5
2
1.5
Vascular
Complications
1.22
1.10
r-PCI
f-PCI
1.06
0.67
0.52
0.5
0.31
0.14
0
Males
Females
Males
Females
Category
Age 75 yrs
0.95 (0.821.12)
Age 75 yrs
1.06 (0.951.19)
Outcome
Bleeding
Complications
3.5
Procedural success
3.07
3
2.5
2
r-PCI
f-PCI
%
1.5
1
Vascular
Complications
1.29
0.76
0.67
0.5
0.19
0.72
0.21
Stable
angina
NSTE
ACS
STEMI
0.79
Stable
angina
NSTE
ACS
0.71 (0.471.06)
0.10
Age 75 yrs
0.31 (0.190.49)
0.01
Men
1.04 (0.921.17)
0.55
Women
1.02 (0.861.22)
0.80
Men
0.53 (0.380.75)
0.01
Women
0.38 (0.240.60)
0.01
Stable angina
1.09 (0.921.28)
0.33
NSTE ACS
0.99 (0.861.12)
0.82
STEMI
0.91 (0.571.46)
0.87
0.01
Procedural success
0.32
Age 75 yrs
STEMI
0.56
0.01
Procedural success
0.88
0.61
2.07
p Value
0.81
0.70
0.01
0.57 (0.390.82)
0.01
NSTE ACS
0.39 (0.270.58)
0.01
*Interaction p value shown in bold; There were no bleeding events among STEMI patients
treated with r-PCI; thus, the interaction could not be examined. Procedure success and Any
bleeding complication models adjusted for American College of Cardiology-National Cardiovascular Data Registry risk score (13).
Abbreviations as in Tables 1 and 2.
Rao et al.
Trends in Radial and Femoral Approaches to PCI
385
REFERENCES
386
Rao et al.
Trends in Radial and Femoral Approaches to PCI